Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
La Jolla Pharmaceutical Co LJPC
Posted On: 01/30/2013 6:42:11 PM
Post# of 66
Avatar
Posted By: BULL2222
Re: BULL2222 #9












































































Title of Securities


to be Registered



Amount


to be


Registered (1)



Proposed


Maximum


Offering Price


per Share (2)



Proposed


Maximum


Aggregate


Offering Price (1)



Amount of


Registration


Fee



Common Stock, $0.0001 par value per share


1,354,798 shares (3) $0.0598 $81,017 $11.05

Common Stock, $0.0001 par value per share


506,300,087 shares (4) $0.0598 $30,276,745 $4,129.75

Common Stock, $0.0001 par value per share


29,268,390 shares (5) $0.0598 $1,750,250 $238.73

Common Stock, $0.0001 par value per share


67,037,105 shares (6) $0.0598 $4,008,819 $546.80

Common Stock, $0.0001 par value per share


1,050,000 shares (7) $0.0598 $62,790 $8.57













(1) Pursuant to Rule 416(a) of the Securities Act of 1933, this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction under the anti-dilution provisions of the standalone inducement awards or the registrant’s 2010 Equity Incentive Plan, as amended (the “ 2010 Plan ”) or the forms of awards granted thereunder.








(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) of the Securities Act of 1933, and based on the average of the high and low sale prices of the registrant’s Common Stock, as quoted on the Over the Counter Bulletin Board on November 9, 2012.








(3) Represents shares of Common Stock reserved for issuance pursuant to options available for grant (but not yet granted) under the 2010 Plan less shares previously registered on form S-8 under the 2010 Plan.








(4) Represents shares of Common Stock reserved for issuance upon the exercise of 506,300,087 inducement options granted on April 10, 2012 to George F. Tidmarsh, M.D., Ph.D. given in connection with his employment.








(5) Represents shares of Common Stock reserved for issuance (i) upon the exercise of 18,907,498 inducement options and (ii) pursuant to an inducement restricted stock unit award for 10,360,892 shares of Common Stock, in each case granted on April 10, 2012 to Saiid Zarrabian given in connection with his services as a director.








(6) Represents shares of Common Stock reserved for issuance (i) upon the exercise of 67,022,886 inducement options and (ii) pursuant to an inducement restricted stock unit award for 14,219 shares of Common Stock, in each case granted on April 10, 2012 to James Rolke given in connection with his employment.








(7) Represents shares of Common Stock reserved for issuance pursuant to an inducement restricted stock unit award for 1,050,000 shares of Common Stock, granted on August 17, 2012 to Chester S. Zygmont, III given in connection with his services as a consultant.








EXPLANATORY NOTE:














(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site